Atlas Trials

Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC

Clinical trial NCT05057247 · COMPLETED

Trial details

NCT number
NCT05057247
Sponsor
Glenn J. Hanna
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic Head and Neck CancerAdvanced Head and Neck CancerAdvanced Head and Neck Squamous Cell Carcinoma
Start date
2021-10-14
Primary completion
2023-10-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.